MyAsthma App - a New Dimension in Asthma Control

GlaxoSmithKlineGlaxoSmithKline (GSK) has announced the launch of MyAsthma, the UK's first, free personalised health application (app) designed to help people over the age of 12 take greater control of their asthma. The app features the Asthma Control Test™ (ACT), a simple 30-second test developed by leading asthma experts, which gives asthma patients a useful measure of their asthma control in an easy-to-understand score. Although many patients are receiving treatment for their asthma, a recent survey in the UK shows that almost 50% do not have their asthma under control.(1) MyAsthma applies new technology to traditional asthma management to provide a daily personalised plan helping patients to manage their asthma more effectively.

"MyAsthma is exciting for people with asthma as it uses new technology to help them better understand and control this chronic disease. MyAsthma can also be used by carers of people with asthma, especially parents and is a great way to teach older children the importance of taking control of their asthma. This creates a habit that they can carry into adulthood, a significant and positive step for the future of asthma care in the UK" said Dr Mike Thomas, Asthma UK Senior Research Fellow with the University of Aberdeen and Chief Medical Adviser, Asthma UK. "Empowering patients to take more control of long-term conditions not only leads to improved health outcomes but also cost savings."

Asthma is a chronic condition of the airways with symptoms including breathing difficulties and sudden episodes of breathlessness.(2) Asthma affects approximately 5.4 million people in the UK(3) with 4.3m adults and 1.1m children, currently receiving treatment for mild, moderate or severe asthma.(3) When not well controlled, asthma symptoms can result in hospitalisation, even fatality. Asthma places a significant economic burden on both individuals and society. The NHS spends around £1 billion a year treating and caring for people with asthma and between 2008 and 2009, up to 1.1 million working days were lost due to breathing or lung problems.(3)

Designed with the support of a panel of asthma experts and Professor Rob Horne, a behavioural psychologist at the University of London, MyAsthma displays localised information on asthma triggers such as pollen count, pollution and weather. It is enabled to help patients track their symptoms and ACT score evolution over time and contains a library with useful information about asthma. An algorithm generates tailored messages, based on a person's ACT score and individual profiles, to help people address the personal barriers they face and to help them improve their management of the condition. MyAsthma is convenient and easy to use allowing patients to track their asthma control at the quick touch of a smartphone screen, which can help to create a more informed dialogue during consultations with their healthcare professional.

For further information, please visit:
http://www.myasthma.com

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

1. Adamek L et al. Poster presented at ATS 2011.
2. National Health Service. Asthma. Last accessed 18 Nov 2011 http://www.nhs.uk/conditions/asthma/Pages/Introduction.aspx
3. Asthma UK. For journalists: key facts & statistics. Last accessed on 17 Nov 2011 http://www.asthma.org.uk/news_media/media_resources/for_journalists_key.html

Most Popular Now

AI Helps Physicians Better Assess the Ef…

In a small but multi-institutional study, an artificial intelligence (AI)-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder...

AI may Detect Earliest Signs of Pancreat…

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed...

Smartwatches and Fitness Bands Reveal In…

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the...

Open Call U4H-2022-PJ2: Call for Proposa…

The Ukraine crisis has an unprecedented impact on the mental health of the displaced people in the EU coming from Ukraine. The conflict and experiences of people in war zones...

AI Reduces Miss Rate of Precancerous Pol…

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reported a team of international researchers led by Mayo Clinic. The study is...

Medical Valley EMN & Volitan Global …

The two healthcare innovation experts Medical Valley EMN and Volitan Global strengthen their existing inbound- and outbound activities through a strategic partnership. The aim is to offer companies access to...

DMEA - Connecting Digital Health Opens w…

26 - 28 April 2022, Berlin, Germany. What plans does the new federal government have concerning the digital transformation of the healthcare sector? What are the initial experiences of doctors regarding...

AI can Predict Probability of COVID-19 v…

Testing shortages, long waits for results, and an over-taxed health care system have made headlines throughout the COVID-19 pandemic. These issues can be further exacerbated in small or rural communities...

Using AI to Detect Cancer from Patient D…

A new way of using artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed by a team including University of Leeds medical...

Oulu University Hospital Expands Partner…

Siemens Healthineers and Oulu University Hospital in Finland have entered a strategic partnership for the next ten years, adding to an existing radiotherapy collaboration to jointly expand and modernize the...

Positive Conclusion to DMEA - Connecting…

26 - 28 April 2022, Berlin, Germany. After three days DMEA, Europe's leading digital health event, came to a successful conclusion - with around 11,000 visitors, more than 500 exhibitors and...

AI-Enabled ECGs may Identify Patients at…

Atrial fibrillation, the most common cardiac rhythm abnormality, has been linked to one-third of ischemic strokes, the most common type of stroke. But atrial fibrillation is underdiagnosed, partly because many...